New-WAVES Study seeks to expand understanding/results from prior study (NCT02585726). Assessing both clinical outcomes and patient satisfaction after treatment with Venaseal/Cyanoacrylate Adhesive Closure System
New WAVES is an investigator initiated protocol that will assess clinical outcomes and patient satisfaction after treatment with VenaSeal(TM)/ Cyanoacrylate Adhesive Closure System 3 years post-treatment. All patients treated from a multi-provider practice, whom meet protocol inclusion criteria, will be invited to consider participation in this study.
Study Type
OBSERVATIONAL
Enrollment
124
Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.
Lake Washington Vascular
Bellevue, Washington, United States
RECRUITINGLake Washington Vascular
Issaquah, Washington, United States
RECRUITINGLake Washington Vascular
Kirkland, Washington, United States
RECRUITINGComplete Closure of Target Vein(s) at 3 years after index treatment
Complete closure is defined as Doppler Ultrasound examination showing closure along entire treated target vein segment with no discrete segments of patency exceeding 5 cm.
Time frame: 3 years post treatment
Venous disease severity assessed via Venous Clinical Severity Score
Assessed via the revised Venous Clinical Severity Score (rVCSS). The rVCSS is an Investigator assessment of the severity of venous reflux disease, assessing signs and symptoms such as pain, varicose veins, venous edema, skin pigmentation, induration, and inflammation.
Time frame: 3 years post treatment
Clinical Severity via Varicose Vein Questionnaire (AVVQ)
Assessed via Aberdeen Varicose Vein Questionnaire (AVVQ) is a disease specific 13 item questionnaire is used to assess the impact of varicose veins on the quality of life, such as pain caused by varicose veins, and the need to take pain medication.
Time frame: 3 years post treatment
Quality of Life and Patient Satisfaction of Treatment: EQ-5D Questionnaire
Assessed via EQ-5D Questionnaire. The EQ-5D is a short generic quality of life survey that is commonly used outside of the United States for health technology assessments. The "health state today" question provides an overall assessment along a 20 cm visual analog scale (VAS) with a range from 0 ("worst imaginable health state") to 100 ("best imaginable health state").
Time frame: 3 years post treatment
Need for adjunctive treatments
Either at the index procedure or at any point following the index procedure
Time frame: 3 years post treatment
Health care utilization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Via chart review and patient questionnaire
Time frame: 3 years post treatment